Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Heart, Lung & Circulation|September 4, 2021
Glucagon-Like Peptide-1 Receptor Agonists and Brain Vascular FunctionEdin Begic, Mirsada Causevic
Journal of Alzheimer'S Disease : JAD|August 18, 2020
Increased Levels of Coagulation Factor XI in Plasma Are Related to Alzheimer's Disease DiagnosisEdin Begic, Suncica Hadzidedic, Slobodan Obradovic, et al.
Journal of Neuropathology and Experimental Neurology|October 25, 2003
Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotypeMirsada Causevic, Nicolas Ramoz, Vahram Haroutunian, et al.
Plos One|February 15, 2019
SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patientsEdin Begic, Suncica Hadzidedic, Ajla Kulaglic, et al.
Molecular Neurodegeneration|December 11, 2007
Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain sheddingAnnat F Ikin, Mirsada Causevic, Steve Pedrini, et al.
Cellular Signalling|December 6, 2014
The Notch intracellular domain represses CRE-dependent transcriptionRania Hallaq, Floriana Volpicelli, Inmaculada Cuchillo-Ibanez, et al.
The Journal of Biological Chemistry|April 16, 2013
Prostate-derived sterile 20-like kinases (PSKs/TAOKs) phosphorylate tau protein and are activated in tangle-bearing neurons in Alzheimer diseaseIgnatius A Tavares, Dona Touma, Steven Lynham, et al.
Plos One|December 30, 2011
Plasma biomarkers of brain atrophy in Alzheimer's diseaseMadhav Thambisetty, Andrew Simmons, Abdul Hye, et al.
Plos One|July 7, 2018
BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brainsMirsada Causevic, Kristina Dominko, Martina Malnar, et al.
Biochemical and Biophysical Research Communications|June 16, 2009
Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic miceRichard Killick, Georgie Scales, Karelle Leroy, et al.
Pageof 2